Zim Laboratories Limited (ZIMLAB) — Cash Flow-to-Debt Ratio
Zim Laboratories Limited (ZIMLAB) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2023, meaning its operating cash flow of Rs81.71 Million could theoretically repay 0% of its total liabilities (Rs1.40 Billion) in one year. Check how aggressively does Zim Laboratories Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zim Laboratories Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zim Laboratories Limited across 13 annual periods. Also explore Zim Laboratories Limited asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zim Laboratories Limited (2013–2025)
Year-by-year debt coverage analysis for Zim Laboratories Limited. For market capitalisation and broader financial context, see Zim Laboratories Limited market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs411.55 Million | Rs2.20 Billion | ▲ +139.4% |
| 2024 | 0.08x | Rs162.78 Million | Rs2.08 Billion | ▼ -70.6% |
| 2023 | 0.27x | Rs375.19 Million | Rs1.41 Billion | ▼ -10.4% |
| 2022 | 0.30x | Rs492.06 Million | Rs1.66 Billion | ▲ +52.7% |
| 2021 | 0.19x | Rs318.51 Million | Rs1.64 Billion | ▲ +51.9% |
| 2020 | 0.13x | Rs219.15 Million | Rs1.71 Billion | ▼ -35.0% |
| 2019 | 0.20x | Rs348.65 Million | Rs1.77 Billion | ▼ -13.2% |
| 2018 | 0.23x | Rs366.13 Million | Rs1.62 Billion | ▼ -0.6% |
| 2017 | 0.23x | Rs320.71 Million | Rs1.41 Billion | ▲ +63.9% |
| 2016 | 0.14x | Rs219.43 Million | Rs1.58 Billion | ▲ +325.4% |
| 2015 | 0.03x | Rs55.85 Million | Rs1.71 Billion | ▲ +44.0% |
| 2014 | 0.02x | Rs33.48 Million | Rs1.48 Billion | ▲ +110.9% |
| 2013 | -0.21x | Rs-231.81 Million | Rs1.11 Billion | — |